Company news
Omeros Corporation news in 2023
Omeros Corporation's news releases, calls and decks from 2023, newest first.
Omeros Corporation Reports Third Quarter 2023 Financial Results
November 8, 2023
Omeros Corporation to Announce Third Quarter Financial Results on November 9, 2023
November 5, 2023
Omeros Announces Online Publication in Advance of ASH Annual Meeting Detailing Narsoplimab Treatment Under Compassionate Use of 15 Patients with Hematopoietic Stem Cell Transplant-associated Thrombotic Microangiopathy
November 2, 2023
Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting
November 1, 2023
Omeros Corporation Hires Andreas Grauer M.D. as Chief Medical Officer
October 18, 2023
Omeros Corporation Provides Update on Interim Analysis of ARTEMIS-IGAN Phase 3 Trial of Narsoplimab in IgA Nephropathy
October 15, 2023
Omeros Corporation Reports Second Quarter 2023 Financial Results
August 8, 2023
Omeros Corporation to Announce Second Quarter Financial Results on Morning of August 9, 2023
August 3, 2023
Omeros Corporation Announces Availability on Its Website of Materials Accompanying Presentations of OMS906 Data at the 2023 European Hematology Association Congress
June 11, 2023
Omeros Corporation Announces Late-Breaking Presentation of OMS906 Data at the 2023 European Hematology Association (EHA) Congress
May 31, 2023
Omeros Corporation Reports First Quarter 2023 Financial Results
May 8, 2023
Omeros Corporation to Announce First Quarter Financial Results on May 9, 2023
May 3, 2023
Omeros Corporation Reports Interim Data with Alternative Pathway Inhibitor OMS906 as Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria
April 24, 2023
Omeros Corporation Awarded $6.69 Million Grant from the National Institute on Drug Abuse for its OMS527 Addiction Program
April 9, 2023
Omeros Corporation Reports Fourth Quarter and Year-End 2022 Financial Results
March 12, 2023
Omeros Corporation Confirms Absence of Financial Exposure to Silicon Valley Bank
March 9, 2023
Omeros Corporation to Announce Fourth Quarter and Year End Financial Results on March 13, 2023
March 6, 2023
Omeros Corporation Receives $200 Million Milestone Payment from Rayner Surgical
February 5, 2023